Status:
RECRUITING
Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV)
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Arteriovenous Malformations
Eligibility:
All Genders
Brief Summary
Cerebral and medullary arteriovenous malformations (AVMs) lead to arterial and venous networks to communicate pathologically, creating an arteriovenous shunt. The occurrence of intracranial haemorrhag...
Detailed Description
Cerebral and medullary arteriovenous malformations (AVMs) are morphologically abnormal vessels located on the surface or in the cerebral or medullary parenchyma. These vascular lesions cause the arter...
Eligibility Criteria
Inclusion
- Patient with a vascular malformation of the cerebral or medullary identified on diagnostic imaging (angio-CT, angio-MRI or diagnostic angiography) for which clinical monitoring alone or intervention (endovascular treatment, surgery or radiosurgery) is planned in the centres participating in the research.
Exclusion
- Pregnant, parturient or breastfeeding woman
Key Trial Info
Start Date :
February 17 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04772963
Start Date
February 17 2022
End Date
October 1 2026
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HOPITAL FONDATION Adolphe de ROTHSCHILD
Paris, France, 75019